1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Gallium: new trials by email Literature Review of Gallium trials Research Report on Gallium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. [68Ga]Ga-PSMA-11, [68Ga]GA-DOTA-TATE, [68Ga]Ga-NeoB - Metastatic Neuroendocrine Prostate Cancer | Phase 1 | Terminated | Novartis Pharmaceuticals | 31 | 2024-07-29 | 2026-11-17 |
| IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) Gallium nitrate - Nontuberculous Mycobacterium Infection | Phase 1 | Recruiting | Chris Goss | 40 | 2021-06-17 | 2025-10-01 |
Cystic Fibrosis (1) · Mycobacterium Infections, Nontuberculous (1) · Mycobacterium avium-intracellulare Infection (1)
Chris Goss (1) · Novartis Pharmaceuticals (1)
United States (2) · France (1) · Germany (1) · Spain (1) · United Kingdom (1)
Christopher H. Goss, MD, MSc (1)
2023 (1)